Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vahid Asgharzadeh

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Parasitology Research|December 8, 2023
Proteases of AcanthamoebaBehroz Mahdavi Poor, Jalil Rashedi, Vahid Asgharzadeh, et al.
Le Infezioni in Medicina|February 11, 2022
Mixed tuberculosis infections in Northwest of IranMohammad Asgharzadeh, Zahra Taghinejad, Behroz Mahdavipoor, et al.
Journal of Medical Case Reports|October 21, 2022
Spontaneous rupture of a large splenic artery aneurysm in a 59-year-old male patient with pemphigus vulgaris: a case reportAhmad Hosseinzadeh, Reza Shahriarirad, Vahid Asgharzadeh Majdazar, et al.
Iranian Journal of Public Health|September 27, 2021
Why the COVID-19 Is Not Significantly Reduced in Iran?Mohammad Asgharzadeh, Behroz Mahdavipoor, Vahid Asgharzadeh, et al.
Le Infezioni in Medicina|December 1, 2020
Risk Factors for COVID-19Jalil Rashedi, Behroz Mahdavi Poor, Vahid Asgharzadeh, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|November 7, 2023
The Association between Diet and Multiple SclerosisVahid Asgharzadeh, Seyyed Amin Seyyed Rezaei, Behroz Mahdavi Poor, et al.
Infectious Disorders Drug Targets|July 20, 2019
Tuberculosis and Diabetes Mellitus in Northwest of IranMahdi Asghari Ozma, Jalil Rashedi, Behroz Mahdavi Poor, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 28, 2026
Association Between Early-Life Self-Medication and Multiple Sclerosis Risk: A Case-Control StudySeyyed Amin Seyyed Rezaie, Vahid Asgharzadeh, Behroz Mahdavipoor, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|May 6, 2020
IFN-γ and TNF-α Gene Polymorphisms in Multiple Sclerosis Patients in Northwest IranMohammad Asgharzadeh, Nima Najafi-Ghalehlou, Behroz M Poor, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 11, 2020
Vitamin D Receptor Gene Polymorphism and the Risk of Multiple Sclerosis in the Azeri Population of IranMahya Pourostadi, Simin Sattarpour, Behroz M Poor, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Parasitology Research|December 8, 2023
Proteases of AcanthamoebaBehroz Mahdavi Poor, Jalil Rashedi, Vahid Asgharzadeh, et al.
Le Infezioni in Medicina|February 11, 2022
Mixed tuberculosis infections in Northwest of IranMohammad Asgharzadeh, Zahra Taghinejad, Behroz Mahdavipoor, et al.
Journal of Medical Case Reports|October 21, 2022
Spontaneous rupture of a large splenic artery aneurysm in a 59-year-old male patient with pemphigus vulgaris: a case reportAhmad Hosseinzadeh, Reza Shahriarirad, Vahid Asgharzadeh Majdazar, et al.
Iranian Journal of Public Health|September 27, 2021
Why the COVID-19 Is Not Significantly Reduced in Iran?Mohammad Asgharzadeh, Behroz Mahdavipoor, Vahid Asgharzadeh, et al.
Le Infezioni in Medicina|December 1, 2020
Risk Factors for COVID-19Jalil Rashedi, Behroz Mahdavi Poor, Vahid Asgharzadeh, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|November 7, 2023
The Association between Diet and Multiple SclerosisVahid Asgharzadeh, Seyyed Amin Seyyed Rezaei, Behroz Mahdavi Poor, et al.
Infectious Disorders Drug Targets|July 20, 2019
Tuberculosis and Diabetes Mellitus in Northwest of IranMahdi Asghari Ozma, Jalil Rashedi, Behroz Mahdavi Poor, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 28, 2026
Association Between Early-Life Self-Medication and Multiple Sclerosis Risk: A Case-Control StudySeyyed Amin Seyyed Rezaie, Vahid Asgharzadeh, Behroz Mahdavipoor, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|May 6, 2020
IFN-γ and TNF-α Gene Polymorphisms in Multiple Sclerosis Patients in Northwest IranMohammad Asgharzadeh, Nima Najafi-Ghalehlou, Behroz M Poor, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 11, 2020
Vitamin D Receptor Gene Polymorphism and the Risk of Multiple Sclerosis in the Azeri Population of IranMahya Pourostadi, Simin Sattarpour, Behroz M Poor, et al.
Pageof 2